September 15, 2021
RegMed Investors’ (RMi) closing bell: follow the bouncing share pricings
September 14, 2021
RegMed Investors’ (RMi) closing bell: key word for today’s session - fragility
September 13, 2021
RegMed Investors’ (RMi) closing bell: sector action, sputtering
September 10, 2021
RegMed Investors’ (RMi) closing bell: losses accelerated as the session closed
September 9, 2021
RegMed Investors’ (RMi) closing bell: sentiment loads its soppiness
September 8, 2021
RegMed Investors’ (RMi) closing bell: another cell and gene therapy session of drip, drip down on thin volume
September 7, 2021
RegMed Investors’ (RMi) closing bell: drip, drip down
September 6, 2021
Happy Labor Day …
September 3, 2021
RegMed Investors’ (RMi) closing bell: the cell and gene therapy highs hit the wall and bounced to the downside
September 2, 2021
RegMed Investors’ (RMi) closing bell: strolling to the upside on low volume
September 1, 2021
RegMed Investors’ (RMi) closing bell: are we in a goldilocks continuum?
August 31, 2021
RegMed Investors’ (RMi) closing bell: August floats bye
August 30, 2021
RegMed Investors’ (RMi) closing bell: the cell and gene therapy sector’s upside collapsed as the session progressed
August 27, 2021
RegMed Investors’ (RMi) closing bell: sector pops on rotation to biotech/healthcare
August 26, 2021
RegMed Investors’ (RMi) closing bell: a challenging session fraught with sorrow
August 25, 2021
RegMed Investors’ (RMi) closing bell: investors do not have an easy consensus as rebounds come and then go
August 23, 2021
RegMed Investors’ (RMi) closing bell: are we chasing the oversold?
August 20, 2021
RegMed Investors’ (RMi) closing bell: a follow the bounce share pricing
August 19, 2021
RegMed Investors’ (RMi) closing bell: a bubblicious session
August 18, 2021
RegMed Investors’ (RMi) closing bell: another early rout but, with no comeback in the cell and gene therapy sector
August 17, 2021
RegMed Investors’ (RMi) closing bell: a rout with a late session comeback in the cell and gene therapy sector
August 16, 2021
RegMed Investors’ (RMi) closing bell: starting the week, the cell and gene therapy sector exhibits an irregular pulse and heartbeat
August 13, 2021
RegMed Investors’ (RMi) closing bell: sector wavers with minimal percentage movement, low volume and lack of breath
August 12, 2021
RegMed Investors’ (RMi) closing bell: cell and gene therapy sector flips positive at mid-day
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.